STXS — Stereotaxis Balance Sheet
0.000.00%
- $207.18m
- $201.94m
- $26.92m
Annual balance sheet for Stereotaxis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 43.9 | 38.7 | 28.4 | 19.8 | 12.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.52 | 5.41 | 5.09 | 3.82 | 3.82 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 52.7 | 51.4 | 43.2 | 33.3 | 26.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.43 | 8.37 | 9.21 | 8.29 | 9.06 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 55.5 | 61 | 53.4 | 41.9 | 46.7 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.6 | 13.3 | 14.3 | 13.2 | 21.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.2 | 21.6 | 21.5 | 20 | 35.3 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 40.2 | 39.4 | 31.9 | 21.9 | 11.4 |
| Total Liabilities & Shareholders' Equity | 55.5 | 61 | 53.4 | 41.9 | 46.7 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |